8797 related articles for article (PubMed ID: 12083498)
1. Tissue factor pathway inhibitor reduces experimental lung metastasis of B16 melanoma.
Amirkhosravi A; Meyer T; Chang JY; Amaya M; Siddiqui F; Desai H; Francis JL
Thromb Haemost; 2002 Jun; 87(6):930-6. PubMed ID: 12083498
[TBL] [Abstract][Full Text] [Related]
2. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells.
Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H
Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705
[TBL] [Abstract][Full Text] [Related]
4. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
Hembrough TA; Swartz GM; Papathanassiu A; Vlasuk GP; Rote WE; Green SJ; Pribluda VS
Cancer Res; 2003 Jun; 63(11):2997-3000. PubMed ID: 12782609
[TBL] [Abstract][Full Text] [Related]
6. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
7. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin.
Amirkhosravi A; Mousa SA; Amaya M; Francis JL
J Thromb Haemost; 2003 Sep; 1(9):1972-6. PubMed ID: 12941039
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide.
Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A
Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486
[TBL] [Abstract][Full Text] [Related]
10. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
[TBL] [Abstract][Full Text] [Related]
11. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.
Carrascal MT; Mendoza L; Valcárcel M; Salado C; Egilegor E; TellerĂa N; Vidal-Vanaclocha F; Dinarello CA
Cancer Res; 2003 Jan; 63(2):491-7. PubMed ID: 12543807
[TBL] [Abstract][Full Text] [Related]
13. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
[TBL] [Abstract][Full Text] [Related]
14. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
Gautam A; Densmore CL; Waldrep JC
Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
[TBL] [Abstract][Full Text] [Related]
16. A factor X-TFPI hybrid protein inhibits B16 melanoma metastatic growth in mice.
Girard TJ
Thromb Res; 2007; 121(3):427-8. PubMed ID: 17555803
[No Abstract] [Full Text] [Related]
17. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
18. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
19. Structure and biology of tissue factor pathway inhibitor.
Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
[TBL] [Abstract][Full Text] [Related]
20. [Experimental study of anti-vascular endothelial growth factor hairpin ribozyme gene inhibiting growth of xenografted tumor of ovarian cancer cells].
Yan R; Xin X; Jin M; Hui H; Wang J; Wang D
Zhonghua Fu Chan Ke Za Zhi; 2002 Nov; 37(11):683-6. PubMed ID: 12487926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]